Melanoma

Trial CA045-001
Cancer Type Melanoma
Hospital(s) Belfast City Hospital
Information

A Phase 3, Randomized, Open-label Study of NKTR-214 Combined with Nivolumab Versus Nivolumab in Participants with Previously Untreated Unresectable or metastatic Melanoma

Trial DANTE
Cancer Type Melanoma
Hospital(s) Belfast City Hospital
Information

A randomised phase III trial to evaluate the Duration of ANti-PD1 monoclonal antibody Treatment in patients with metastatic mElanoma